The role of cannabis, cannabidiol and other cannabinoids in chronic pain. The perspective of physicians

M Köstenberger, G Nahler, TM Jones… - Journal of Neuroimmune …, 2022 - Springer
Currently, there is a renewed interest in treatments with medical cannabis and
cannabinoids. Based on an increasing number of publications over the last decades that …

[HTML][HTML] Controlled administration of cannabis to mitigate cannabis-attributable harm among recreational users: a quasi-experimental study in Germany

J Manthey, J Kalke, J Rehm, M Rosenkranz… - …, 2020 - ncbi.nlm.nih.gov
Background: New approaches are required to slow down or reverse increasing trends of
levels of delta-9-tetrahydrocannabinol (THC) and cannabis-attributable hospitalizations in …

[HTML][HTML] Endometriosis–an indication for cannabinoids?

G Nahler - Traditional Medicine, 2020 - traditionalmedicines.org
Corresponding Author: Gerhard Nahler, Dr. med., Dr. phil., CIS Clinical Investigation Support
GmbH, Kaiserstrasse 43, 1070 Wien, Austria, Tel:+ 43 1 52340150; Fax:+ 43 1 523401599 …

[PDF][PDF] Pilot Trials: The Swiss Approach to Cannabis Legalisation

J MORAND - Legalisation and Decriminalisation of Narcotic Drugs … - library.oapen.org
Pilot Trials: The Swiss Approach to Cannabis Legalisation Page 227 Pilot Trials: The Swiss
Approach to Cannabis Legalisation JEANNE MORAND This paper outlines the regulation …